随着疫情的继续，COVID-19大流行对精神健康的影响将会增加，即使在大流行过去后也会持续下去。我们开发了11项冠状病毒大流行焦虑量表(CPAS-11)来测量与COVID-19大流行相关的焦虑症状，以帮助识别可能需要心理健康服务的个体。在开发规模项目时，我们考虑了先前关于焦虑症状和菲律宾临床转诊病例报告的症状的研究和理论.该量表在菲律宾样品(N=925)中验证。探索性因素分析显示对应躯体症状和非躯体症状的两个因素；验证性因素分析显示出与双因素模型的良好拟合。CPAS-11表现出良好的内部一致性，收敛有效性和发散有效性，和筛选的准确性。15分的截止分数显示出足够的敏感性和特异性来区分GAD-7筛查的参与者。结果支持CPAS-11作为一种筛查工具来识别经历COVID-19相关焦虑的个体的可行性。
The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety.
PDF(Sci-hub)